OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Shah on Biomarkers in Gastric/GEJ Cancer

November 19th 2019

Manish A. Shah, MD, discusses biomarkers in gastric and gastroesophageal junction cancer.

Dr. Chaft on Investigational Neoadjuvant Immunotherapy Approaches in NSCLC

November 18th 2019

Jamie E. Chaft, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses investigational neoadjuvant immunotherapy approaches in non–small cell lung cancer (NSCLC).

Dr. Namakydoust on the Use of Next-Generation Sequencing in Lung Cancer

November 18th 2019

Azadeh Namakydoust, MD, FACP, thoracic oncologist, Memorial Sloan Kettering Cancer Center, discusses the use of next-generation sequencing (NGS) in lung cancer.

Dr. Alshaygy on Resection Margin for Dermatofibrosarcoma Protuberans

November 18th 2019

Ibrahim S. Alshaygy, MD, MSC, discusses research suggesting a smaller surgical resection margin for dermatofibrosarcoma protuberans.

Dr. Borghaei on Emerging Biomarkers in NSCLC

November 16th 2019

Hossein Borghaei, DO, MS, discusses emerging biomarkers of response to immunotherapy in non–small cell lung cancer (NSCLC).

Dr. Tauer on the Potential Implications of Biosimilars on Cancer Research Funding

November 16th 2019

Kurt W. Tauer, MD, FACP, discusses the potential implications of biosimilars on cancer research funding.

Dr. Lonial on Treatments in Heavily Pretreated Multiple Myeloma

November 16th 2019

Sagar Lonial, MD, FACP, discusses treatments for patients with heavily pretreated multiple myeloma.

Dr. Perales on Ongoing Studies With CAR T Cells in DLBCL

November 16th 2019

Miguel-Angel Perales, MD, discusses replacing autologous stem cell transplant with CAR T-cell therapy in diffuse large B-cell lymphoma.

Dr. Cohen on the Use of Chemoimmunotherapy in CLL

November 16th 2019

Jonathon B. Cohen, MD, MS, discusses the role of chemoimmunotherapy in chronic lymphocytic leukemia.

Dr. Sartor on the VISION Trial in mCRPC

November 16th 2019

A. Oliver Sartor, MD, discusses the phase III VISION trial in patients with prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer.

Dr. Kim on Treatment for BRAF-Mutant Colon Cancer

November 16th 2019

Richard Kim, MD, discusses treatment options for BRAF-mutant colon cancer.

Dr. Hidalgo Medina on Neoadjuvant Therapy in Pancreatic Cancer

November 16th 2019

Manuel Hidalgo Medina, MD, PhD, discusses the emergence of neoadjuvant chemotherapy and radiation in pancreatic cancer.

Dr. Rule on the FDA Approval of Zanubrutinib in MCL

November 15th 2019

Simon Rule, MD, PhD, professor of hematology, Plymouth University Medical School, United Kingdom, discusses the FDA approval of zanubrutinib (Brukinsa) in mantle cell lymphoma (MCL).

Dr. Vidal on Potential of [Fam-] Trastuzumab Deruxtecan in HER2+ Breast Cancer

November 15th 2019

Gregory Vidal, MD, PhD, discusses the potential of [fam-] trastuzumab deruxtecan in HER2-positive breast cancer.

Dr. Levy on Molecular Drivers in NSCLC

November 15th 2019

Benjamin P. Levy, MD, discusses the identification of molecular drivers in non–small cell lung cancer.

Dr. Bestvina on the KEYNOTE-407 Trial in Squamous NSCLC

November 15th 2019

Christine Bestvina, MD, discusses the phase III KEYNOTE-407 trial in squamous non–small cell lung cancer.

Dr. Giralt on Evaluating MRD in Multiple Myeloma

November 15th 2019

Sergio A. Giralt, MD, professor of medicine at Weill Cornell Medical College, and chief, Adult Bone Marrow Transplant Service, Melvin Berlin Family Chair in Multiple Myeloma, at Memorial Sloan Kettering Cancer Center, discusses methods of evaluating measurable residual disease (MRD) in multiple myeloma.

Dr. Leath on Agents Under Investigation in Cervical Cancer

November 15th 2019

Charles A. Leath III, MD, gynecologic oncologist at the University of Alabama at Birmingham, discusses agents under investigation in cervical cancer.

Dr. Somer on Hesitancy Regarding Biosimilar Use in Oncology

November 15th 2019

Bradley G. Somer, MD, associate professor, Department of Hematology and Medical Oncology, University of Tennessee Health Science Center, medical oncologist, senior partner, Executive Cancer Council, and head of strategic expansion/development, West Cancer Center Research Program, West Cancer Center, explains where the hesitancy regarding biosimilar use in oncology.

Dr. Schwartzberg on Increasing Competition With Biosimilars in Oncology

November 14th 2019

Lee S. Schwartzberg, MD, FACP, explains how biosimilars could lead to increased competition in oncology.